Rafael S Rios

发表

M. Zheng, Dan-Qin Sun, C. Byrne, 2020, Metabolism: clinical and experimental.

Comparison between MAFLD and NAFLD definitions for identifying patients at higher risk of chronic kidney disease

H. Zhang, M. Zheng, Dan-Qin Sun, 2020 .

Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis

M. Zheng, Wen-Yue Liu, Xiao-dong Wang, 2021, Journal of clinical and translational hepatology.

Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

M. Zheng, C. Byrne, G. Targher, 2020, Journal of gastroenterology and hepatology.

Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease

M. Zheng, C. Byrne, G. Targher, 2021, British Journal of Nutrition.

PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease

M. Zheng, C. Byrne, G. Targher, 2021, Journal of clinical and translational hepatology.

C>G variant influences the association between 2 visceral fat and significant fibrosis in biopsy-proven NAFLD

M. Zheng, C. Byrne, G. Targher, 2021 .

FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease

M. Zheng, Wen-Yue Liu, C. Byrne, 2020, British Journal of Nutrition.

Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?

M. Zheng, C. Byrne, G. Targher, 2022, iLiver.

TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy‐proven nonalcoholic fatty liver disease

M. Zheng, C. Byrne, G. Targher, 2021, Journal of gastroenterology and hepatology.

Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy‐confirmed NAFLD

M. Zheng, C. Byrne, Kenneth I. Zheng, 2021, Journal of hepato-biliary-pancreatic sciences.

Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease

M. Zheng, Wen-Yue Liu, C. Byrne, 2020, Journal of gastroenterology and hepatology.

Recommendations and Clinical Guidance for Children with Metabolic-associated Fatty Liver Disease during the COVID-19 Pandemic

M. Zheng, Kenneth I. Zheng, K. I. Zheng, 2021, Journal of clinical and translational hepatology.

Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis.

M. Zheng, Kenneth I. Zheng, Yong-Ping Chen, 2021, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease?

M. Zheng, C. Byrne, G. Targher, 2021, Expert review of gastroenterology & hepatology.

COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies

Sven Van Poucke, M. Zheng, Wen-Yue Liu, 2020, Journal of clinical and translational hepatology.

Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease

M. Zheng, Wen-Yue Liu, C. Byrne, 2021, Journal of clinical and translational hepatology.

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma

M. Zheng, Kenneth I. Zheng, K. I. Zheng, 2021, Chinese medical journal.

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease

M. Zheng, C. Byrne, G. Targher, 2020, Chinese medical journal.

Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis

M. Zheng, Wen-Yue Liu, C. Byrne, 2021, Journal of clinical and translational hepatology.

Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients

M. Ghanbari, M. Zheng, Wen-Yue Liu, 2021, Clinical and molecular hepatology.

A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study.

M. Zheng, X. Ye, C. Byrne, 2021, Hepatobiliary surgery and nutrition.

Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study

V. Wong, J. Dufour, J. Schattenberg, 2023, Chinese medical journal.

Data sharing during COVID-19 pandemic: what to take away

M. Zheng, Kenneth I. Zheng, K. I. Zheng, 2020, Expert review of gastroenterology & hepatology.

COVID-19 Cross-Infection and Pressured Ulceration Among Healthcare Workers: Are We Really Protected by Respirators?

M. Zheng, K. I. Zheng, Qi-qiang Zeng, 2020, Frontiers in Medicine.

Associations of 17-beta dehydrogenase 13 variants with liver histology in Chinese patients with MAFLD

M. Zheng, Wen-Yue Liu, M. Eslam, 2021 .

Clinical Features and Long-Term Outcomes of Patients Diagnosed with MASLD, MAFLD, or Both.

Dan-Qin Sun, Wen-Yue Liu, A. Lonardo, 2024, Journal of hepatology.